Prevalence of genetic thrombophilic polymorphisms in the Sri Lankan population - implications for association study design and clinical genetic testing services

dc.contributor.authorDissanayake, V.H.W.
dc.contributor.authorWeerasekera, L.Y.
dc.contributor.authorGammulla, C.G.
dc.contributor.authorJayasekara, R.W.
dc.date.accessioned2015-05-19T09:25:45Z
dc.date.available2015-05-19T09:25:45Z
dc.date.issued2009
dc.identifier.citationExperimental and Molecular Pathology, 87(2):p.159-162
dc.identifier.reportnumberFR 1485
dc.identifier.researchgrantnumberSIDA/2004/BT/001
dc.identifier.urihttps://dl.nsf.gov.lk/handle/1/19399
dc.subjectMedical Sciences
dc.subjectMethylenetetrahydrofolate reductase
dc.subjectFactor V
dc.subjectFactor II
dc.subjectPopulation genetics
dc.titlePrevalence of genetic thrombophilic polymorphisms in the Sri Lankan population - implications for association study design and clinical genetic testing services
dc.typeArticle

Files